Albert Glozman

Albert Glozman is a highly experienced Senior Scientist currently at PDI since April 2021, focusing on analytical support for new drug product development and analytical method development and validation. Prior experience includes leadership roles as Principal Scientist at Cosette Pharmaceuticals, where Albert led a team in ANDA development programs, and as Senior Scientist at Teva Pharmaceuticals, where significant contributions were made to analytical method development within FDA compliance. Additional roles at Novartis, Taro Pharmaceuticals, Altana, and Eon Labs further highlight Albert's extensive background in analytical methods, training personnel, and supporting pharmaceutical formulations. Albert holds a Master’s degree in Chemistry from Long Island University and a combined Bachelor’s and Master’s degree in Education, Chemistry, and Biology from Kursk State University.